Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Capital Leases (2019 - 2026)

Insmed's Capital Leases history spans 12 years, with the latest figure at $19.8 million for Q1 2026.

  • Quarterly Capital Leases fell 14.81% to $19.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $19.8 million through Mar 2026, down 14.81% year-over-year, with the annual reading at $20.7 million for FY2025, 13.9% down from the prior year.
  • Capital Leases came in at $19.8 million for Q1 2026, down from $20.7 million in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $29.6 million in Q4 2022 to a low of $19.8 million in Q1 2026.
  • The 5-year median for Capital Leases is $24.1 million (2024), against an average of $24.7 million.
  • Year-over-year, Capital Leases surged 110.14% in 2022 and then fell 14.81% in 2026.
  • Insmed's Capital Leases stood at $29.6 million in 2022, then fell by 8.81% to $27.0 million in 2023, then fell by 10.96% to $24.1 million in 2024, then fell by 13.9% to $20.7 million in 2025, then decreased by 4.34% to $19.8 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Capital Leases are $19.8 million (Q1 2026), $20.7 million (Q4 2025), and $21.6 million (Q3 2025).